title: Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus.
abstract: Biochemical markers of early changes that are characteristic for diabetic microangiopathy are not completely understood. We investigated activities of serum N-acetyl-beta-glucosaminidase (NAG), tissue plasminogen activator and erythrocyte superoxide dismutase in well defined groups of type 1 diabetic patients. Patients were selected on the basis of 4 year follow-up observation. Forty-two type 1 diabetic patients were subdivided into those without retinopathy (n = 13) throughout the study, those with newly developed or worsened retinopathy (n = 12) during 4 years and those with retinopathy already established at the beginning of the study and without evidence of its progression (n = 17). All diabetic patients had albustix-negative urine. A significant increase of the mean serum NAG activity during 4 years was found only in patients without retinopathy (P < 0.01) whereas no changes of the altered enzyme activities were present in patients with developing and established retinopathy. The mean activity of tissue plasminogen activator was elevated in all groups of diabetic patients compared with healthy subjects (P < 0.001). A significant positive correlation was found between plasminogen activator and serum NAG (r = 0.51, P < 0.01). Erythrocyte superoxide dismutase was higher in diabetic patients than in healthy persons (P < 0.01) but no differences were observed between the patients with or without retinopathy. Superoxide dismutase positively correlated with NAG (r = 0.57, P < 0.01). We conclude that early functional changes precede a morphological development of diabetic retinopathy as was evident from the altered enzyme activities.
authors.affiliation: Department of Internal Medicine 3, Faculty of Medicine 1, Charles University, Prague, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Skrha
authors.forename: A
authors.initials: A
authors.lastname: Hodinár
authors.forename: J
authors.initials: J
authors.lastname: Kvasnicka
authors.forename: V
authors.initials: V
authors.lastname: Stibor
authors.forename: M
authors.initials: M
authors.lastname: Sperl
authors.forename: P
authors.initials: P
authors.lastname: Stolba
authors.forename: J
authors.initials: J
authors.lastname: Hilgertová
mesh_terms: D000118:Acetylglucosaminidase / Q000097:blood*; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000201:enzymology*; D003930:Diabetic Retinopathy / Q000201:enzymology*; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D013482:Superoxide Dismutase / Q000097:blood*; D010959:Tissue Plasminogen Activator / Q000097:blood*
chemical_list: D000118:Acetylglucosaminidase; D006442:Glycated Hemoglobin; D013482:Superoxide Dismutase; D010959:Tissue Plasminogen Activator